Willis Towers Watson Public stock forecast 2026–2030
Analysts' average 12-month price target for Willis Towers Watson Public is 358.11, 8.9% above the current price of 328.88. Their targets range from 310.00 to 405.00.
Of the 15 firms that rated Willis Towers Watson Public in the past 12 months, 10 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 310.00 to 405.00, with an average of 358.11.
| Strong buy | 0 | |
| Buy | 10 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 405.00 |
| Average target | 358.11 |
| Lowest target | 310.00 |
| Current price | 328.88 |
Willis Towers Watson Public price target history
Have analysts recently raised or lowered their Willis Towers Watson Public price target and rating?
How analysts rate Willis Towers Watson Public, month by month
10 of 15 firms rate it buy now, against 8 of 10 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Willis Towers Watson Public analyst upgrades, downgrades and price targets
The latest rating change came on 3 August 2026, when Citigroup downgraded Willis Towers Watson Public from Buy to Neutral. The most recent new target came from Mizuho Securities on 2 November 2026: 370.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 2 Nov 2026 | Mizuho Securities Yaron Kinar | — | 349.00 → 370.00 | +6.0% | 324.42 |
| 12 Oct 2026 | Wells Fargo | Reiterated · Overweight | 379.00 → 364.00 | -4.0% | 296.26 |
| 7 Oct 2026 | Mizuho Securities | Reiterated · Outperform | 380.00 → 349.00 | -8.2% | 291.98 |
| 7 Oct 2026 | Barclays | Reiterated · Equal Weight | 318.00 → 332.00 | +4.4% | 291.98 |
| 6 Oct 2026 | Morgan Stanley Bob Huang | Reiterated · Equal Weight | 350.00 → 310.00 | -11.4% | 290.98 |
| 16 Sept 2026 | Mizuho Securities Yaron Kinar | Reiterated · Outperform | 406.00 → 380.00 | -6.4% | 321.97 |
| 19 Aug 2026 | Morgan Stanley | Reiterated · Equal Weight | 315.00 → 350.00 | +11.1% | 327.90 |
| 3 Aug 2026 | Cantor Fitzgerald | Reiterated · Neutral | 344.00 → 380.00 | +10.5% | 341.09 |
| 3 Aug 2026 | UBS Brian Meredith | Reiterated · Buy | 382.00 → 405.00 | +6.0% | 341.04 |
| 3 Aug 2026 | Morgan Stanley Bob Huang | — | 275.00 → 315.00 | +14.5% | 341.39 |
| 3 Aug 2026 | Citigroup | Downgraded · Buy → Neutral | — | — | — |
| 31 Jul 2026 | Robert W. Baird Mark Marcon | — | 335.00 → 385.00 | +14.9% | 336.05 |
| 31 Jul 2026 | Mizuho Securities Yaron Kinar | — | 361.00 → 406.00 | +12.5% | 336.05 |
| 15 Jul 2026 | Atlantic Equities | — | 360.00 | — | 287.30 |
| 15 Jul 2026 | Piper Sandler Paul Newsome | Reiterated · Overweight | 283.00 → 317.00 | +12.0% | 288.74 |
| 9 Jul 2026 | Cantor Fitzgerald | Reiterated · Neutral | 354.00 → 344.00 | -2.8% | 292.58 |
| 9 Jul 2026 | Mizuho Securities | Reiterated · Outperform | 338.00 → 361.00 | +6.8% | 292.58 |
| 8 Jul 2026 | UBS | Reiterated · Buy | 374.00 → 382.00 | +2.1% | 291.47 |
| 9 Jun 2026 | UBS | Reiterated · Buy | 409.00 → 374.00 | -8.6% | 258.12 |
| 6 May 2026 | Raymond James | — | 340.00 | — | 261.92 |
| 6 May 2026 | Citigroup | Upgraded · Neutral → Buy | — | — | — |
| 5 May 2026 | Mizuho Securities | Reiterated · Outperform | 353.00 → 338.00 | -4.2% | 259.37 |
| 1 May 2026 | Morgan Stanley | — | 345.00 → 275.00 | -20.3% | 259.00 |
| 1 May 2026 | Robert W. Baird Mark Marcon | — | 335.00 | — | 260.24 |
| 1 May 2026 | Evercore ISI | Reiterated · Outperform | 383.00 → 360.00 | -6.0% | 263.78 |
| 1 May 2026 | Piper Sandler Paul Newsome | Reiterated · Overweight | 341.00 → 283.00 | -17.0% | 256.20 |
| 1 May 2026 | BMO Capital | Upgraded · Market Perform → Outperform | 300.00 | — | 256.20 |
| 30 Apr 2026 | Truist Financial Mark Hughes | — | 400.00 → 320.00 | -20.0% | 256.33 |
| 13 Apr 2026 | Mizuho Securities | Reiterated · Outperform | 392.00 → 353.00 | -9.9% | 285.59 |
| 9 Apr 2026 | Cantor Fitzgerald | Reiterated · Neutral | 345.00 → 354.00 | +2.6% | 287.86 |
| 11 Mar 2026 | Barclays | Upgraded · Underweight → Equal Weight | — | — | — |
| 23 Feb 2026 | Piper Sandler Paul Newsome | Reiterated · Overweight | 387.00 → 341.00 | -11.9% | 301.81 |
| 9 Feb 2026 | UBS | Reiterated · Buy | 398.00 → 409.00 | +2.8% | 319.38 |
| 4 Feb 2026 | Truist Financial | Reiterated · Buy | 400.00 | — | 338.86 |
| 4 Feb 2026 | Mizuho Securities | — | 388.00 → 392.00 | +1.0% | 335.10 |
| 4 Feb 2026 | Wells Fargo | Reiterated · Overweight | 366.00 → 379.00 | +3.6% | 335.10 |
| 14 Jan 2026 | Cantor Fitzgerald Ryan Tunis | Reiterated · Neutral | 345.00 | — | 329.28 |
| 14 Jan 2026 | Mizuho Securities | — | 386.00 → 388.00 | +0.5% | 327.42 |
| 13 Jan 2026 | Wells Fargo Elyse Greenspan | Reiterated · Overweight | 356.00 → 366.00 | +2.8% | 329.45 |
| 8 Jan 2026 | Barclays | Reiterated · Underweight | 303.00 → 318.00 | +5.0% | 331.38 |
| 7 Jan 2026 | Goldman Sachs | — | 375.00 | — | 331.38 |
| 7 Jan 2026 | Evercore ISI | Reiterated · Outperform | 387.00 → 383.00 | -1.0% | 333.38 |
| 15 Dec 2025 | Mizuho Securities Yaron Kinar | — | 386.00 | — | 330.76 |
| 12 Dec 2025 | Wells Fargo | Reiterated · Overweight | 377.00 → 356.00 | -5.6% | 325.52 |
| 20 Nov 2025 | Barclays Alex Scott | Reiterated · Underweight | 341.00 → 303.00 | -11.1% | 317.26 |
Willis Towers Watson Public EPS and revenue estimates
Analysts expect Willis Towers Watson Public's EPS to grow 18.7% a year until 2028. Over the last 5 years it grew 16.3% a year, and over the last 3 years 21.9%.
Analysts expect Willis Towers Watson Public's revenue to grow 6.2% a year until 2028, faster than over the last 5 years (2.4% a year) and the last 3 years (3.1%).
Revenue
EPS
Does Willis Towers Watson Public beat earnings estimates?
On average, analysts' EPS estimate was 4.1% off the result, either way, and their revenue estimate 2.9%, over the last 12 quarters.
- EPS beats
- 71 / 102
- Revenue beats
- 11 / 20
- Average EPS surprise, last 12
- +3.7%
- Since
- July 2001
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 29 Oct 2026 | 3.59 | 3.63 | +1.1% | 2.45B | 2.46B | +0.2% |
| Q2 FY2026 | 30 Jul 2026 | 3.11 | 3.35 | +7.7% | 2.42B | 2.47B | +2.0% |
| Q1 FY2026 | 30 Apr 2026 | 3.66 | 3.72 | +1.6% | 2.41B | 2.41B | -0.1% |
| Q4 FY2025 | 3 Feb 2026 | 7.96 | 8.12 | +2.0% | 2.85B | 2.94B | +2.9% |
| Q3 FY2025 | 30 Oct 2025 | 3.05 | 3.07 | +0.7% | 2.27B | 2.29B | +0.6% |
| Q2 FY2025 | 31 Jul 2025 | 2.63 | 2.86 | +8.7% | 2.23B | 2.26B | +1.4% |
| Q1 FY2025 | 24 Apr 2025 | 3.21 | 3.13 | -2.5% | 2.28B | 2.22B | -2.6% |
| Q4 FY2024 | 4 Feb 2025 | 8.01 | 8.13 | +1.5% | 3.05B | 3.04B | -0.5% |
| Q3 FY2024 | 31 Oct 2024 | 2.72 | 2.93 | +7.7% | 2.28B | 2.29B | +0.3% |
| Q2 FY2024 | 25 Jul 2024 | 2.34 | 2.55 | +9.0% | 2.27B | 2.27B | -0.2% |
| Q1 FY2024 | 25 Apr 2024 | 3.25 | 3.29 | +1.2% | 2.37B | 2.34B | -1.2% |
| Q4 FY2023 | 6 Feb 2024 | 7.05 | 7.44 | +5.5% | 2.38B | 2.91B | +22.3% |
Willis Towers Watson Public stock price 2026–2030: scenarios
If Willis Towers Watson Public's earnings keep growing at the 16.6% a year analysts expect to FY2028, it would earn about 36.96 a share in FY2030. At the P/E it has traded at over the last five years (15.8 to 27.2) that is 584.37 to 1,004.37 a share, or 804.75 at its average P/E of 21.8. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 19.84 | 313.63 | 431.90 | 539.04 |
| FY2027 | 22.91 | 362.17 | 498.75 | 622.46 |
| FY2028 | 27.20 | 430.14 | 592.36 | 739.29 |
| FY2029 (extrapolated) | 31.71 | 501.36 | 690.43 | 861.70 |
| FY2030 (extrapolated) | 36.96 | 584.37 | 804.75 | 1,004.37 |
Each year's EPS is the analysts' consensus to FY2028; the years after continue its 16.6% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (15.8, 21.8, 27.2).
Is Willis Towers Watson Public stock undervalued or overvalued?
Willis Towers Watson Public's P/E of 20.0 is around the middle of its 5-year range (6.5 to 217.3, median 19.3). It is in line with its own history. Buyers pay about the usual price for each point of growth: a PEG of 1.1 on expected growth against 1.2 on its median P/E and past five years' growth. At its usual P/E (17.9 × EPS of 16.46), Willis Towers Watson Public's fair value is 294.72; the price, 328.88, is 11.6% above it. Its forward P/E, on the consensus for FY2026, is 16.6.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (6.5 and 29.2). The price against its P/E range
- Price to earnings ratio (TTM)
- 19.98
- Five-year median P/E
- 19.28
- Five-year P/E range
- 6.5 – 217.3
- Forward P/E (FY2026)
- 16.58
- PEG ratio
- 1.21
- To the average target
- +8.9%
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.09146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% | |
| 108.445 | 201.41108Price 108.45248 | +85.7% |
Furthest below the fair value on each stock's page, updated every day.
